Onconetix Inc. announced it has received a delisting notice from Nasdaq due to its failure to file its Quarterly Report for the period ending March 31, 2025. Additionally, the company is not in compliance with the minimum bid price requirement, which could lead to its delisting. A hearing before the Nasdaq Hearings Panel is scheduled for May 27, 2025, which will determine the future of Onconetix's listing status. In the meantime, the company intends to file its pending reports promptly to regain compliance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.